H.C. Wainwright Reiterates Buy Rating on VYNE Therapeutics (VYNE)

Go back to H.C. Wainwright Reiterates Buy Rating on VYNE Therapeutics (VYNE)
(NASDAQ: VYNE) Delayed: 28.56 --0 (-0%)
Previous Close $28.56    52 Week High
Open $28.56    52 Week Low
Day High $28.56    P/E N/A 
Day Low $28.56    EPS
Volume 2,685,854